Rituximab increases the cytotoxicities of vincristine and hydroxyurea through caspase-dependent and caspase-independent cell death, respectively
. . Tabal S, Elbanani A, Deyab M, Abulayha A. . Cancer Biother Radiopharm. 2015 Apr;30(3):125-31. doi: 10.1089/cbr.2014.1769. Epub 2015 Feb 25. Abstract In the treatment of B cell non-Hodgkin’s lymphoma, rituximab is used in combination with different chemotherapeutics to improve its efficacy, but the mechanisms involved are not fully understood. The authors examined the …